The researchers of a new review have examined the relationship between cellular senescence and bone marrow cancers, looking at how senescence can ultimately fuel cancer development and how malignant cells induce senescence [1].
Well this is good news. Now they just need to pour every dime into the manufacturing and hurry the hell up.
The Food and Drug Administration (FDA) has approved the first coronavirus diagnostic test that can be conducted entirely at the point of care.
The test from California-based Cepheid will deliver results in about 45 minutes — much faster than current tests that require a sample to be sent to a centralized lab, where results can take days.
The test has been designed to operate on any of Cepheid’s more than 23,000 automated GeneXpert Systems worldwide, of which 5,000 are in the U.S., the company said. The systems are already being used to test for conditions such as HIV and tuberculosis.
These materials have self-healing capabilities, just like Wolverine’s skin.
Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs.
The Rutgers coauthored study, led by researchers at Rochester Institute of Technology, is published in the journal ACS Applied Materials & Interfaces.
“The rapid identification of drug-resistant bacteria allows health care providers to prescribe the right drugs, boosting the chances of survival,” said coauthor Ruo-Qian (Roger) Wang, an assistant professor in the Department of Civil and Environmental Engineering in the School of Engineering at Rutgers University-New Brunswick.
Coronavirus has claimed at least 10,447 lives with a total of 254,701 confirmed cases worldwide. A total of 89,071 people have recovered from the virus. The outbreak has led to panic and pandemonium. As we reported yesterday, there are only three major types of treatments: antiviral drug, antibody solution (including blood plasma) and vaccine.
Even though the need to develop new vaccines seems to be getting a lot of headlines, vaccine, however, does not provide the immediate relief for people who are already infected with the virus. In addition, experts are saying that it may take between 12 to 24 months before the vaccine becomes available. Some are going as far as saying it could be 2022 before we see a COVID-19 vaccine.
In the meantime, more companies are coming out with existing antiviral and experimental drugs that have proven to show promising results in treating COVID-19 patients. While there are no FDA-approved therapeutics or drugs to treat, cure or prevent COVID-19, there are several FDA-approved treatments that may help ease the symptoms from a supportive care perspective.
Final NASA Seats on Soyuz in 2020
Posted in government, space, space travel
By Bill D’Zio
Soyuz creeping up in cost
NASA has been dependent on Russia for transport to and from the ISS. Over time the cost of seats on the Soyuz crew vehicle have risen.
No Autonomous Trucks? Wait, What? ‘…it resembled conventional human-operated transportation vehicles, but with one exception — there was no driver’s cabin.’ — Philip K. Dick, 1955.
Elon Musk’s Traffic Tunnel Challenge Is Boring ‘The car vibrated… threading the maze of local tubes.’ — Jack Vance, 1954.
HVSD, Kitty Hawk’s Electric Plane Very quiet commuter plane offers VTOL service.
As Big As A Biltong
Posted in 3D printing
World’s Largest 3D Printer re: Philip K. Dick on 3/1/2020: Science Fiction in the News.
VIKING LifeCraft evacuation system
Posted in futurism
This evacuation system can save 800 people from a sinking ship.
Everywhere from business to medicine to the climate, forecasting the future is a complex and absolutely critical job. So how do you do it—and what comes next?